Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Martin McCarter to Treatment Outcome

This is a "connection" page, showing publications Martin McCarter has written about Treatment Outcome.

 
Connection Strength
 
 
 
0.469
 
  1. Paniccia A, Edil BH, Schulick RD, Byers JT, Meguid C, Gajdos C, McCarter MD. Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study. Medicine (Baltimore). 2014 Dec; 93(27):e198.
    View in: PubMed
    Score: 0.038
  2. Jones EL, Jones TS, Paniccia A, Merkow JS, Wells DM, Pearlman NW, McCarter MD. Smaller pelvic volume is associated with postoperative infection after pelvic salvage surgery for recurrent malignancy. Am J Surg. 2014 Dec; 208(6):1016-22; discussion 1021-2.
    View in: PubMed
    Score: 0.037
  3. Jones TS, Jones EL, Gao D, Pearlman NW, Robinson WA, McCarter M. Management of external ear melanoma: the same or something different? Am J Surg. 2013 Sep; 206(3):307-13.
    View in: PubMed
    Score: 0.034
  4. Kounalakis N, Gao D, Gonzalez R, Becker M, Lewis K, Poust J, Pearlman N, Robinson W, McCarter M. A neoadjuvant biochemotherapy approach to stage III melanoma: analysis of surgical outcomes. Immunotherapy. 2012 Jul; 4(7):679-86.
    View in: PubMed
    Score: 0.032
  5. Escobar GA, Robinson WA, Nydam TL, Heiple DC, Weiss GJ, Buckley L, Gonzalez R, McCarter MD. Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report. BMC Cancer. 2007 Jan 17; 7:13.
    View in: PubMed
    Score: 0.022
  6. Furtado Neves PJ, Simioni A, Ishida AH, Kim SP, Gleisner AL, Mungo B, McCarter MD, Jacobs DL, Malgor EA, Malgor RD. Trends and Outcomes of Surgical Reconstruction of the IVC after Oncologic Resection. J Am Coll Surg. 2026 Jun 01; 242(6):1568-1578.
    View in: PubMed
    Score: 0.021
  7. Wang X, Li T, Eljilany I, Soupir A, Radmacher M, Agius P, Sukrithan V, Ratan A, McCarter M, Salhia B, Colman H, Naqash AR, Puzanov I, Arnold S, Marin-Acevedo JA, Ganesan S, Churchman M, Hwu P, Rodriguez PC, Dalton WS, Weiner GJ, Tarhini AA. Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors. Nat Commun. 2025 Nov 13; 16(1):9968.
    View in: PubMed
    Score: 0.020
  8. Roaten JB, Partrick DA, Pearlman N, Gonzalez RJ, Gonzalez R, McCarter MD. Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents. J Pediatr Surg. 2005 Jan; 40(1):232-5.
    View in: PubMed
    Score: 0.019
  9. Stuart CM, Dyas AR, Yee EJ, Thielen O, Bronsert MR, Mungo B, McCarter MD, Randhawa SK, David EA, Michell JD, Meguid RA. Patient, facility, and surgical factors associated with significant delays to esophagectomy and subsequent poor outcomes: An analysis of 16,486 cases. J Thorac Cardiovasc Surg. 2025 05; 169(5):1385-1395.e5.
    View in: PubMed
    Score: 0.019
  10. Dravillas CE, Coleman SS, Hoyd R, Caryotakis G, Denko L, Chan CHF, Churchman ML, Denko N, Dodd RD, Eljilany I, Hardikar S, Husain M, Ikeguchi AP, Jin N, Ma Q, McCarter MD, Osman AEG, Robinson LA, Singer EA, Tinoco G, Ulrich CM, Zakharia Y, Spakowicz D, Tarhini AA, Tan AC. The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors. Cancer Res Commun. 2024 08 01; 4(8):1978-1990.
    View in: PubMed
    Score: 0.018
  11. Dyas AR, Mungo B, Bronsert MR, Stuart CM, Mungo AH, Mitchell JD, Randhawa SK, David E, Stewart CL, McCarter MD, Meguid RA. National trends in technique use for esophagectomy: Does primary surgeon specialty matter? Surgery. 2024 02; 175(2):353-359.
    View in: PubMed
    Score: 0.018
  12. McCarter MD, Quan SH, Busam K, Paty PP, Wong D, Guillem JG. Long-term outcome of perianal Paget's disease. Dis Colon Rectum. 2003 May; 46(5):612-6.
    View in: PubMed
    Score: 0.017
  13. Dyas AR, Stuart CM, Bronsert MR, Schulick RD, McCarter MD, Meguid RA. Minimally invasive surgery is associated with decreased postoperative complications after esophagectomy. J Thorac Cardiovasc Surg. 2023 07; 166(1):268-278.
    View in: PubMed
    Score: 0.016
  14. McCarter MD, Fong Y. Role for surgical cytoreduction in multimodality treatments for cancer. Ann Surg Oncol. 2001 Jan-Feb; 8(1):38-43.
    View in: PubMed
    Score: 0.014
  15. Gergen AK, Halpern AL, Helmkamp L, Torphy RJ, White AM, Mitchell JD, Meguid RA, Scott CD, Gleisner AL, McCarter MD, Weyant MJ. Outcomes After Converted Minimally Invasive to Open Esophagectomy in Patients With Esophageal Cancer. Ann Thorac Surg. 2021 11; 112(5):1593-1599.
    View in: PubMed
    Score: 0.014
  16. Halpern AL, Friedman C, Torphy RJ, Al-Musawi MH, Mitchell JD, Scott CD, Meguid RA, McCarter MD, Weyant MJ, Gleisner AL. Conversion to open surgery during minimally invasive esophagectomy portends worse short-term outcomes: an analysis of the National Cancer Database. Surg Endosc. 2020 08; 34(8):3470-3478.
    View in: PubMed
    Score: 0.013
  17. Janssen QP, Buettner S, Suker M, Beumer BR, Addeo P, Bachellier P, Bahary N, Bekaii-Saab T, Bali MA, Besselink MG, Boone BA, Chau I, Clarke S, Dillhoff M, El-Rayes BF, Frakes JM, Grose D, Hosein PJ, Jamieson NB, Javed AA, Khan K, Kim KP, Kim SC, Kim SS, Ko AH, Lacy J, Margonis GA, McCarter MD, McKay CJ, Mellon EA, Moorcraft SY, Okada KI, Paniccia A, Parikh PJ, Peters NA, Rabl H, Samra J, Tinchon C, van Tienhoven G, van Veldhuisen E, Wang-Gillam A, Weiss MJ, Wilmink JW, Yamaue H, Homs MYV, van Eijck CHJ, Katz MHG, Groot Koerkamp B. Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis. J Natl Cancer Inst. 2019 08 01; 111(8):782-794.
    View in: PubMed
    Score: 0.013
  18. Chapman BC, Gajdos C, Hosokawa P, Henderson W, Paniccia A, Overbey DM, Gleisner A, Schulick RD, McCarter MD, Edil BH. Comparison of laparoscopic to open pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma. Surg Endosc. 2018 05; 32(5):2239-2248.
    View in: PubMed
    Score: 0.011
  19. Smith B, Jones EL, Kitano M, Gleisner AL, Lyell NJ, Cheng G, McCarter MD, Abdel-Misih S, Backes FJ. Influence of tumor size on outcomes following pelvic exenteration. Gynecol Oncol. 2017 11; 147(2):345-350.
    View in: PubMed
    Score: 0.011
  20. Chapman BC, Gleisner A, Ibrahim-Zada I, Overbey DM, Paniccia A, Meguid C, Brauer B, Gajdos C, McCarter MD, Schulick RD, Edil BH. Laparoscopic pancreaticoduodenectomy: changing the management of ampullary neoplasms. Surg Endosc. 2018 Feb; 32(2):915-922.
    View in: PubMed
    Score: 0.011
  21. Corless CL, Ballman KV, Antonescu CR, Kolesnikova V, Maki RG, Pisters PW, Blackstein ME, Blanke CD, Demetri GD, Heinrich MC, von Mehren M, Patel S, McCarter MD, Owzar K, DeMatteo RP. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. J Clin Oncol. 2014 May 20; 32(15):1563-70.
    View in: PubMed
    Score: 0.009
  22. DeMatteo RP, Ballman KV, Antonescu CR, Corless C, Kolesnikova V, von Mehren M, McCarter MD, Norton J, Maki RG, Pisters PW, Demetri GD, Brennan MF, Owzar K. Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial. Ann Surg. 2013 Sep; 258(3):422-9.
    View in: PubMed
    Score: 0.009
  23. Merkow RP, Bilimoria KY, McCarter MD, Phillips JD, DeCamp MM, Sherman KL, Ko CY, Bentrem DJ. Short-term outcomes after esophagectomy at 164 American College of Surgeons National Surgical Quality Improvement Program hospitals: effect of operative approach and hospital-level variation. Arch Surg. 2012 Nov; 147(11):1009-16.
    View in: PubMed
    Score: 0.008
  24. Ripley RT, Gajdos C, Reppert AE, Macdermott T, McCarter MD, Pearlman NW. Sequential radiofrequency ablation and surgical debulking for unresectable colorectal carcinoma: thermo-surgical ablation. J Surg Oncol. 2013 Feb; 107(2):144-7.
    View in: PubMed
    Score: 0.008
  25. Cheng SS, Nordenholz K, Matero D, Pearlman N, McCarter M, Gajdos C, Hamiel C, Baer A, Luzier E, Tran ZV, Olson T, Queensland K, Lutz R, Wischmeyer P. Standard subcutaneous dosing of unfractionated heparin for venous thromboembolism prophylaxis in surgical ICU patients leads to subtherapeutic factor Xa inhibition. Intensive Care Med. 2012 Apr; 38(4):642-8.
    View in: PubMed
    Score: 0.008
  26. Merkow RP, Bilimoria KY, McCarter MD, Chow WB, Gordon HS, Stewart AK, Ko CY, Bentrem DJ. Effect of histologic subtype on treatment and outcomes for esophageal cancer in the United States. Cancer. 2012 Jul 01; 118(13):3268-76.
    View in: PubMed
    Score: 0.008
  27. Merkow RP, Bilimoria KY, McCarter MD, Chow WB, Ko CY, Bentrem DJ. Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: assessment of 987 hospitals. Ann Surg Oncol. 2012 Feb; 19(2):357-64.
    View in: PubMed
    Score: 0.007
  28. Gajdos C, Macdermott T, McCarter MD, Pearlman NW. Combined thermal-surgical ablation of locally advanced abdominopelvic malignancies. Ann Surg Oncol. 2011 May; 18(5):1267-73.
    View in: PubMed
    Score: 0.007
  29. Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg. 2009 Jan; 208(1):53-61.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)